Polsinelli·FDA / LIFE SCIENCES REGULATORY
HHS Interim Policy Sets Six Peptides for 503A Compounders
HHS announced Oct. 30, 2026 an interim enforcement discretion policy letting Section 503A compounders use BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500 under certain circumstances.
hhs-enforcement-discretion503a-compoundingpeptide-compoundingcompounding-pharmaciesregulatory-discretion
Read the original firm alert → Wednesday, November 11, 2026